Browsing by Author Llovet i Bayer, Josep Maria

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 29 to 45 of 45 < previous 
Issue DateTitleAuthor(s)
25-Jan-2017Objective response by mRECIST as a predictor and potential surrogate end point of overall survival in advanced HCCLencioni, Riccardo; Montal, Robert; Torre, Ferran; Park, Joong-Won; Decaens, Thomas; Raoul, Jean-Luc; Kudo, Masatoshi; Chang, Charissa Y.; Ríos, José; Boige, Valerie; Assenat, Eric; Kang, Yoon-Koo; Lim, Ho-Yeong; Walters, Ian; Llovet i Bayer, Josep Maria
14-Nov-2016Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinomaBollard, Julien; Miguela, Verónica; Ruiz de Galarreta, Marina; Venkatesh, Anu; Bian, C. Billie; Roberto, Mark P.; Tovar, Victoria; Sia, Daniela; Molina Sánchez, Pedro; Nguyen, Christie B.; Nakagawa, Shigeki; Llovet i Bayer, Josep Maria; Hoshida, Yujin; Lujambio, Amaia
14-Nov-2020Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumabReig, María; Galle, Peter R.; Kudo, Masatoshi; Finn, Richard; Llovet i Bayer, Josep Maria; Metti, Andrea L.; Schelman, William R.; Liang, Kun; Wang, Chunxiao; Widau, Ryan C.; Abada, Paolo; Zhu, Andrew X.
27-Jul-2020Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular CarcinomaFinn, Richard S.; Ikeda, Masafumi; Zhu, Andrew X.; Sung, Max W.; Baron, Ari D.; Kudo, Masatoshi; Okusaka, Takuji; Kobayashi, Masahiro; Kumada, Hiromitsu; Kaneko, Shuichi; Pracht, Marc; Mamontov, Konstantin; Meyer, Tim; Kubota, Tomoki; Dutcus, Corina E.; Saito, Kenichi; Siegel, Abby B.; Dubrovsky, Leonid; Mody, Kalgi; Llovet i Bayer, Josep Maria
15-Nov-2017Pilot study of living donor liver transplantation for patients with HCC exceeding Milan criteriaLlovet i Bayer, Josep Maria; Pavel, Mihai; Rimola, Jordi; Diaz, Maria Alba; Colmenero, Jordi; Saavedra, David; Fondevila Campo, Constantino; Ayuso Colella, Carmen; Fuster Obregón, Josep; Ginès i Gibert, Pere; Bruix Tudó, Jordi; García-Valdecasas Salgado, Juan Carlos
Dec-2015Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation.Miltiadous, Oriana; Sia, Daniela; Hoshida, Yujin; Fiel, Maria Isabel; Harrington, Andrew N.; Thung, Swan N.; Seng Tan, Poh; Dong, Hui; Revill, Kate; Chang, Charissa Y.; Roayaie, Sasan; Byrne, Thomas J.; Mazzaferro, Vincenzo; Rakela, Jorge; Florman, Sander; Schwartz, Myron; Llovet i Bayer, Josep Maria
Aug-2020Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2Kudo, Masatoshi; Galle, Peter R.; Llovet i Bayer, Josep Maria; Finn, Richard S.; Vogel, Arndt; Motomura, Kenta; Assenat, Eric; Merle, Philippe; Brandi, Giovanni; Daniele, Bruno; Okusaka, Takuji; Tomášek, Jiří; Borg, Christophe; Dadduzio, Vincenzo; Morimoto, Manabu; Pracht, Marc; Jen, Min-Hua; Widau, Ryan C.; Shinozaki, Kenta; Yoshikawa, Reigetsu; Zhu, Andrew X.
1-Jan-2020Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trialsZhu, Andrew X.; Nipp, Ryan D.; Finn, Richard S.; Galle, Peter R.; Llovet i Bayer, Josep Maria; Blanc, Jean Frederic; Okusaka, Takuji; Chau, Ian; Cella, David; Girvan, Alicia; Gable, Jonathon; Bowman, Lee; Wang, Chunxiao; Hsu, Yanzhi; Abada, Paolo; Kudo, Masatoshi
31-Mar-2019Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survivalLlovet i Bayer, Josep Maria; Montal, Robert; Villanueva, Augusto
20-Mar-2014Reply to X. Qi et al ' Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?'Llovet i Bayer, Josep Maria; Johnson, Philip J.
20-Feb-2014Search: A phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinomaZhu, Andrew X.; Rosmorduc, Olivier; Evans, T.R. Jeffry; Ross, Paul J.; Santoro, Armando; Carrilho, Flair José; Bruix Tudó, Jordi; Qin, Shukui; Thuluvath, Paul J.; Llovet i Bayer, Josep Maria; Leberre, Marie-Aude; Jensen, Markus; Meinhardt, Gerold; Kang, Yoon-Koo
24-Jun-2021Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma.Craig, Amanda J.; Garcia-Lezana, Teresa; Ruiz de Galarreta, Marina; Villacorta-Martin, Carlos; Kozlova, Edgard G; Martins-Filho, Sebastiao N.; von Felden, Johann; Ahsen, Mehmet Eren; Bresnahan, Erin; Hernandez Meza, Gabriela; Labgaa, Ismail; D'Avola, Delia; Schwartz, Myron; Llovet i Bayer, Josep Maria; Sia, Daniela; Thung, Swan N.; Losic, Bojan; Lujambio, Amaia; Villanueva, Augusto
2-Aug-2017Translating '–omics' results into precision medicine for hepatocellular carcinomaSia, Daniela; Llovet i Bayer, Josep Maria
24-Aug-2017Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinomaTorrecilla, Sara; Harrington, Andrew N.; Sia, Daniela; Zhang, Zhongyang; Cabellos, Laia; Cornella, Helena; Moeini, Agrin; Campreciós Figueras, Genís; Leow, Wei-Quiang; Fiel, Maria Isabel; Hao, Ke; Bassaganyas, Laia; Mahajan, Milind; Thung, Swan N.; Villanueva, Augusto; Florman, Sander; Schwartz, Myron; Llovet i Bayer, Josep Maria
1-Mar-2017Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinomaTovar, Victoria; Cornella, Helena; Moeini, Agrin; Vidal, Samuel; Hoshida, Yujin; Sia, Daniela; Peix, Judit; Cabellos, Laia; Alsinet, Clara; Torrecilla, Sara; Martínez Quetglas, Iris; Lozano Salvatella, Juan José; Desbois-Mouthon, Christele; Sole, Manel; Domingo Domènech, Josep Maria; Villanueva, Augusto; Llovet i Bayer, Josep Maria
1-Apr-2015Unique genomic profile of fibrolamellar hepatocellular carcinomaCornella, Helena; Alsinet, Clara; Sayols, Sergi; Zhang, Zhongyang; Hao, Ke; Cabellos, Laia; Hoshida, Yujin; Vila Casadesús, Maria; Villanueva, Augusto; Thung, Swan N.; Ward, Stephen C.; Rodríguez-Carunchio, Leonardo; Imbeaud, Sandrine; Lachenmayer, Anja; Quaglia, Alberto; Nagorney David M.; Minguez, Beatriz; Carrilho, Flair José; Robert, Lewis R.; Mazzaferro, Vincenzo; Schwartz, Myron; Esteller, Manel; Heaton, Nigel D.; Zucman-Rossi, Jessica; Llovet i Bayer, Josep Maria
17-Mar-2015YAP Inhibition restores Hepatocyte differentiation in advanced HCC, leading to tumor regressionFitamant, Julien; Kottakis, Filippos; Benhamouche, Samira; Tian, Helen S.; Chuvin, Nicolas; Parachoniak, Christine A.; Nagle, Julia M.; Perera, Rushika M.; Lapouge, Marjorie; Deshpande, Vikram; Zhu, Andrew X.; Lai, Albert; Min, Bosun; Hoshida, Yujin; Avruch, Joseph; Sia, Daniela; Campreciós Figueras, Genís; McClatchey, Andrea I.; Llovet i Bayer, Josep Maria; Morrissey, David; Raj, Lakshmi; Bardeesy, Nabeel